Zachariah Nealy, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Angiotensin II for the Treatment of Vasodilatory Shock
New England Journal of Medicine
Volume: 377
Date: 01 2017

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Critical Care Medicine
Volume: 46
Date: 01 2018

Genome-first evaluation of heart disease associated with Titin-truncating variants
Circulation
Volume: 140
Date: 07 2019

Metastatic Cancer Masquerading as Acute Coronary Syndrome
Cureus
Date: 08 2020

A Rare Case of Restrictive Cardiomyopathy Presenting With Large, Recurrent Pericardial Effusions
J Investig Med High Impact Case Rep
Date: 01 2021

Prognostic Implication of Contrast Allergy in Patients with Emergency Premedication before Undergoing Percutaneous Coronary Intervention
International Journal of Cardiology
Date: 01 2021
doi.org/10.1016/j.ijcard.2020.12.091

Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification
Heart Fail Clin
Volume: 19
Date: 10 2023
www.clinicalkey.com/#!/content/playContent/1-s2.0-S1551713623000338?returnurl=https:%2F%2Flinkinghub

Pilot Study of Supervised Exercise and Intensive Medical Therapy in Patients With Ischemia With No Evidence of Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction
Am J Cardiol .
Volume: 214
Date: 03 2024
pubmed.ncbi.nlm.nih.gov/38181860/